NIH-funded research R01 grant

Malaria Reservoir Study II: reducing parasite variety to help eliminate malaria in West Africa

Official title: Malaria Reservoir Study (MRS) II: reducing parasite diversity to break intervention resilience in Plasmodium falciparum populations at high endemicity

Funded at New York University · NIH-11373888 · Data updated 2026-11-12

This grant tests whether reducing the diversity of malaria parasite strains in West Africa can make elimination efforts more effective for people living in high-endemic areas.

More Resilience research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$352,497
NIH project number1R01TW013268-01
Project IDNIH-11373888 on NIH RePORTER

Who could benefit from this research

Could help

Children and adults in Ghana and similar high-endemic regions who are affected by malaria transmission.

Less likely to help

Individuals not exposed to malaria transmission in settings outside the study areas may not directly benefit.

What this research studies

This project focuses on people in Ghana and surrounding areas where malaria is common. Researchers will track how many different parasite strains are circulating and how this diversity relates to transmission, using blood samples and new molecular methods. The study will connect data on parasite diversity with patterns of infection over time to see if narrowing diversity could reduce transmission. By studying real-world transmission in a high-endemic setting, the team hopes to identify strategies that could shorten the path to elimination.

Why it matters

Potential benefit: If successful, the work could lead to smarter malaria control strategies that reduce infections by targeting diverse parasite strains.

How similar studies have gone: Prior research suggests complexity of parasite diversity influences transmission, but this project tests a targeted approach in a real-world setting.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Pascual, Mercedes — New York University
  • Study coordinator: Pascual, Mercedes

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.